Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Brower Enterprises
WARNING LETTER
•Brower Enterprises•December 7, 2012

Brower Enterprises – FDA Warning Letter, Dec 7, 2012

Record Details

An FDA inspection of Brower Enterprises in December 2012 revealed significant violations of dietary supplement Current Good Manufacturing Practice (CGMP) regulations (21 CFR 111), rendering products like Myristoleate PLUS Cetyl Myristoleate (CMO), Coral Calcium Formula, Ultra Ellagic Plus Formula, and WOW adulterated. Subsequent labeling reviews in 2013 found these products promoted with disease claims (e.g., for arthritis, cancer) on websites, classifying them as unapproved new drugs (21 U.S.C. §§ 321(g)(1)(B), 321(p), 355(a)) and misbranded (21 U.S.C. § 352(f)(1)) due to inadequate directions for use. CGMP deficiencies included lacking written procedures for quality control (21 CFR 111.103, 111.140(b)(1)), holding/distributing (21 CFR 111.453), returned products (21 CFR 111.503), and product complaints (21 CFR 111.553, 111.560). The firm also failed to establish product specifications (21 CFR 111.70(f)) and collect reserve samples (21 CFR 111.83(a)). The FDA emphasized the firm's ultimate responsibility as a distributor for CGMP compliance. Additionally, products were misbranded (21 U.S.C. § 343(q)(5)(F)) due to non-compliant labeling under 21 CFR 101.36, including incorrect ingredient listing, missing Daily Value information, improper nutrition panel formatting, incorrect serving sizes, and failure to identify products as "dietary supplement" (21 U.S.C. § 343(s)(2)(B)). Other misbranding issues involved non-compliant nutrient content claims (21 U.S.C. § 343(r)(1)(A)), unlisted capsule ingredients (21 U.S.C. § 343(i)(2)), and missing botanical plant parts (21 U.S.C. § 343(s)(2)(C)). The firm's initial response was inadequate. Brower Enterprises must promptly correct all violations, prevent recurrence, and notify FDA within 15 working days, with potential regulatory actions including seizure, injunction, and re-inspection fees.

Company
Brower Enterprises
Inspection date
December 7, 2012
Product type
Food
Office
Minneapolis District Office
Person
  • Michael Dutcher (Acting Assistant Commissioner)
View Company Profile

ID · 71bc748c-4ed0-4594-ba53-6d8ec2a57ffc

Violation Codes10
21 U.S.C. 343(q)(5)(F)21 CFR 11121 U.S.C. 321(g)(1)(B)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 342(g)(1)21 U.S.C. 343(s)(2)(B)21 U.S.C. 343(r)(1)(A)21 U.S.C. 343(i)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Brower Enterprises
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.